It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Humans can be thought of as a complex of both microbial and human cells, a 'super-organism' containing over 100 trillion microbiota that are essential for nutrition, immunity and pathogen resistance. Whilst some are harmful, the majority of human cell and microbial cell interactions are mutually beneficial, and essential to human physiologic functions and day to day activities[12]. Research on the human microbiome aims to elucidate the relationship between human health, physiology, and behaviour and the various microbial communities present in different areas of our body (including the mucosa, gastrointestinal tract, urogenital system and skin)[13,14].
The human microbiome is the entire complement of microorganisms that exists in and on every human body. ….rapid advances in human microbiome research involve collecting large amounts of data on microorganisms that exist in symbiotic relationships with the human body. Currently it is not clear [legally] whether these microorganisms should be considered part of or separate from the human body.
The Common Fund's Human Microbiome Project (HMP) aims to characterize the microbial communities found at several different sites on the human body, including nasal passages, oral cavities, skin, gastrointestinal tract, and urogenital tract, and to analyze the role of these microbes in human health and disease.
Biobanks, loosely defined as large collections of biological tissues samples, often with some degree of linked clinical or medical information, have received considerable attention in the ELSI (ethical, legal, social issues of genome research) and scientific literature in recent years[1-3]. This attention is due not just to the complexity of the issues raised by biobank related research, but also because they call into question established research ethics norms and accepted practices[4]. The nature of these ethical conundrums has been well documented, with research focused on issues such as privacy, informed consent, ownership of samples and information, secondary use of biological specimens, benefit sharing and governance [5-8]. While these biobank issues remain problematic and unresolved, other areas of science are moving ahead rapidly, and have the potential to further complicate matters[9]. In particular, this paper considers recent large scale research efforts towards studying the human microbiome, and the potential social and ethical implications of this research for biobanks.
Originally posted by soficrow
reply to post by starwarsisreal
True. But the common link will NOT be ethnicity - these bioweapons will target groups that share the same or similar microbiota, probably through water, air and food sources - the common links will be area (of birth and main residence) and income.
edit on 22/12/11 by soficrow because: clarif.
Originally posted by DerepentLEstranger
Originally posted by soficrow
reply to post by starwarsisreal
True. But the common link will NOT be ethnicity - these bioweapons will target groups that share the same or similar microbiota, probably through water, air and food sources - the common links will be area (of birth and main residence) and income.
....proof that the american eugenicists, who financed/advised hitler, tried to topple Roosevelt and impose a fascist dictatorship in the US, and received all those nazi war-criminals with open arms and US citizenship are alive,well and active.
the bush clan was and is a member of said group followers of the Secret Covenant.
it's time for the round-up methinks, and i'm not talking about fertilizer.
proof that US government is composed of criminals?
Biobanks Information Paper
Biobanks are generally large collections of human biological materials (biospecimens) linked to relevant personal and health information (which may include health records, family history, lifestyle and genetic information) and held specifically for use in health and medical research. Their object is to provide a resource for researchers to use to advance our understanding of human health and disease. Biobanks are seen as increasingly important to research in two broad areas: understanding the risk factors that underlie complex diseases, and translating biomedical research into real improvements in health care, especially through advances in pharmacogenomics and personalised medicine, to minimise adverse drug reactions and match drugs more effectively to the patient.
…Over the last decade, a number of such biobanks have been established in several countries (Hirtzlin et al 2003), including the Icelandic Health Sector Database, the Estonian Genome Project, UK Biobank, Generation Scotland, and the CARTaGENE project in Quebec; and others are planned, including the Joondalup Family Health Study in Western Australia. Advancements in bioinformatics and biotechnology have made it possible to store biospecimens and data on an unprecedented scale and, with globalisation and growing interest in trans-national sharing of biobank resources, there is an increasing push to harmonise biobank processes and regulation. This is an important consideration for those establishing or managing a biobank.
…The emerging trend towards the establishment of biobanks poses a number of legal, ethical and regulatory challenges. Regardless of size, biobanks inherently involve some risk due to the sensitive status of the data they contain. Their success also depends on community support and willingness to participate. For this reason it has become clear in every jurisdiction that seeks to establish or use biobanks that a mechanism for maximising public trust is critically important (Campbell 2007).
This Information Paper draws on the international and Australian literature to discuss best practice in biobanks across six broad areas: establishment (including discontinuation); consent; data management; governance; access; and commercialisation and benefit sharing.
Guidelines for human biobanks, genetic research databases and associated data
The potential for commercial exploitation of the unique population health resources and biobanks in WA raises complex issues for the State, academic institutions and the community.
More than 300 million biospecimens are stored in the United States in public and private repositories known as biobanks.
…may lead to new diagnostic tests and targeted treatments for specific diseases, as well as open the way to personalized medicine.
Collecting and storing biospecimens raises ethical challenges concerning how to obtain informed consent, protect privacy, and disclose research results.
Other issues concern the ownership of biospecimens as intellectual property and government oversight of biobanks to ensure ethical use of biospecimens.
…..challenges include matters involving informed consent, privacy and confidentiality, disclosure of research results, intellectual property, and biobank governance.